Agea (years)
|
57.1 (13.0)
|
57.8 (9.7)
|
60.1 (9.5)
|
Female, n (%)
|
8 (33.3)*
|
5 (19.2)*
|
34 (91.9)
|
Disease duration since diagnosisb (years)
|
7.5 (3.2–22.8)*
|
10.3 (0.8–27.6)*
|
0.9 (0–23.5)
|
Organ involvement HH, n (%)
|
Aminotransferase elevation
|
4 (16.7)
|
2 (7.7)
|
-
|
Liver fibrosis/cirrhosis
|
0
|
5 (19.2)¥
|
Impaired glucose tolerance
|
1 (4.2)
|
2 (7.7)
|
Diabetes mellitus
|
2 (8.3)
|
3 (11.5)
|
Cardiomyopathy
|
0
|
0
|
Morning stiffnessb (minutes)
|
0 (0–10)
|
3 (0–180)
|
7.5 (0–120)
|
EGAcb (mm)
|
0 (0–29)
|
13.5 (0–61)
|
10 (1–53)
|
PGAcb (mm)
|
5 (0–65)
|
25 (0–74)
|
25 (0–77)
|
Pain handscb (mm)
|
0.5 (0–18)
|
31 (0–72)
|
24.5 (0–86)
|
Pain hipcb (mm)
|
1 (0–44)
|
10.5 (0–58)
|
6 (0–91)
|
Pain kneecb (mm)
|
0.5 (0–50)
|
25 (0–76)
|
10 (0–86)
|
Pain anklecb (mm)
|
1 (0–60)
|
35.5 (0–96)*
|
3 (0–86)
|
Hand functioncb (mm)
|
4.5 (0–66)
|
39.5 (0–100)
|
47 (0–92)
|
Bony swollen jointsb
|
0 (0–12)
|
2.5 (0–14)*
|
7 (0–24)
|
≥1 Bony swollen joint, n (%)
|
8 (33.3)
|
16 (61.5)**
|
36 (97.3)
|
Tender jointsb
|
0 (0–31)
|
4 (0–29)
|
3 (0–40)
|
≥1 Tender joint, n (%)
|
6 (25.0)
|
22 (84.6)
|
30 (81.1)
|
Swollen jointsb
|
0 (0–1)
|
0 (0–7)
|
0 (0–6)
|
≥1 Swollen joint, n (%)
|
2 (8.3)
|
6 (23.1)
|
8 (21.6)
|
ESRb (mm/1st hour)
|
9 (0–29)
|
8.5 (1–36)
|
6 (2–34)
|
CRPb (mg/L)
|
0.5 (0–4)*
|
0.5 (0–4.2)*
|
1.3 (0.1–12.6)
|
Ferritinb (at visit) (ng/ml)
|
83.6 (28–1060)
|
66.1 (14–853)
|
100.0 (19–266)
|